Archive
Proactive news snapshot: Remote Monitored Systems, OptiBiotix Health, Columbus Energy Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
LON:VAL
ValiRx is a drug development company, which focuses on the translation of scientific innovation into clinical candidates for cancer, related conditions and women’s health. The company's specialised business model connects science, finance and commerce to accelerate early-stage drug development. It identifies proprietary and novel drug candidates with the potential to improve patient lives, providing the expertise and investment required for optimised development and value creation.
310 stories · page 5 of 16
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including redT, Rockfire, Oilex, SPDI and Orosur Mining
The publication is intended to be the first in a series of results-based reports on VAL401, an antipsychotic drug that has been re-purposed for use in oncology
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at the day's major movers, including Local Shopping REIT, Just Group, Photo-Me, Lb-Shell, Avacta and ValiRx
Participants in the trial treated with VAL201 displayed a “statistically significant correlation” for reductions over time in testosterone and prostate-specific antigen (PSA), commonly used markers for disease progression in prostate cancer
Investments and investor services
The UK premier index finished down around 56 points at 6,721 on Monday
Archive
A look at some winning and losing shares in the UK equity market on Wednesday
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
All of the current patients have received the escalated dose, meaning VAL201 is now on the home stretch of the early-stage study
The FTSE 100 falls 35 points to 7,025, while Dow falls more than 300 points
The results’ publication onto ClinicalTrials.gov gives them further validation
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, featuring Hardy Oil & Gas, Amerisur Resources, ECR, CMC, Low & Bonar, Corero Network Security and Learning Technologies Group
VAL401 is ValiRx’s most advanced compound, with earlier trial results suggesting it can improve quality of life and chances of survival of lung cancer patients
The AIM-listed firm said it issued 76,666,666 new ordinary shares at a price of 1.50p each in the placing undertaken by the company's broker, Novum Securities
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the London market's biggest risers and fallers on Thursday
Archive
A glance at some of the day's highlights from the Proactive Investors newswire